Cargando…
Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis
Cardiac fibroblasts play a key role in chronic heart failure. The conversion from cardiac fibroblast to myofibroblast as a result of cardiac injury, will lead to excessive matrix deposition and a perpetuation of pro-fibrotic signaling. Cardiac cell therapy for chronic heart failure may be able to ta...
Autores principales: | Bracco Gartner, Tom C. L., Deddens, Janine C., Mol, Emma A., Magin Ferrer, Marina, van Laake, Linda W., Bouten, Carlijn V. C., Khademhosseini, Ali, Doevendans, Pieter A., Suyker, Willem J. L., Sluijter, Joost P. G., Hjortnaes, Jesper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497755/ https://www.ncbi.nlm.nih.gov/pubmed/31080805 http://dx.doi.org/10.3389/fcvm.2019.00052 |
Ejemplares similares
-
Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis
por: Bracco Gartner, Thomas C. L., et al.
Publicado: (2022) -
Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury
por: Deddens, Janine C., et al.
Publicado: (2017) -
Myocardial Disease and Long-Distance Space Travel: Solving the Radiation Problem
por: Meerman, Manon, et al.
Publicado: (2021) -
Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles
por: van den Akker, F., et al.
Publicado: (2018) -
Cardiac Progenitor Cell–Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation
por: Maring, Janita A., et al.
Publicado: (2018)